-
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1083-91
PMID: 23471984
-
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
J Clin Invest. 1998 Nov 1;102(9):1662-73
PMID: 9802880
-
Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.
J Clin Invest. 2012 Mar;122(3):911-22
PMID: 22293178
-
Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Am J Physiol Cell Physiol. 2010 Jul;299(1):C97-110
PMID: 20375277
-
The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7.
J Biol Chem. 2000 Mar 10;275(10):7095-100
PMID: 10702276
-
The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer.
Oncol Lett. 2013 Dec;6(6):1565-1572
PMID: 24260047
-
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
Adv Pharmacol. 1999;46:151-208
PMID: 10332503
-
Expression of GPC3 protein and its significance in lung squamous cell carcinoma.
Med Oncol. 2012 Jun;29(2):663-9
PMID: 21556932
-
Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression, angiogenesis, and metastasis of gastric carcinoma in vitro and in vivo.
Gastroenterol Res Pract. 2012;2012:752940
PMID: 22888341
-
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.
Cell. 1997 Jan 24;88(2):277-85
PMID: 9008168
-
Heparan sulfate: a complex polymer charged with biological activity.
Chem Rev. 2005 Jul;105(7):2745-64
PMID: 16011323
-
Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response.
Blood. 2014 Jan 2;123(1):101-12
PMID: 24065244
-
Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.
EMBO J. 2006 Jul 12;25(13):3045-55
PMID: 16763549
-
Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
J Cell Biol. 1995 Feb;128(4):673-85
PMID: 7532175
-
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.
J Clin Invest. 2013 Nov;123(11):4786-98
PMID: 24216509
-
Heparanase expression in primary and metastatic pancreatic cancer.
Cancer Res. 2001 Jun 15;61(12):4655-9
PMID: 11406531
-
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.
Expert Opin Ther Targets. 2010 Sep;14(9):935-49
PMID: 20629619
-
Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action.
J Biol Chem. 2000 Mar 17;275(11):7964-74
PMID: 10713114
-
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Cancer Res. 2002 Aug 15;62(16):4690-5
PMID: 12183427
-
RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2.
Oncogene. 2014 Jul 3;33(27):3528-37
PMID: 23975428
-
Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase.
Neoplasia. 2011 May;13(5):445-52
PMID: 21532885
-
Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.
Cell. 1994 Dec 16;79(6):1015-24
PMID: 7528103
-
Cell-surface co-receptors: emerging roles in signaling and human disease.
Trends Biochem Sci. 2005 Nov;30(11):611-21
PMID: 16185874
-
M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis.
PLoS One. 2011;6(6):e21106
PMID: 21698156
-
Hallmarks of cancer: the next generation.
Cell. 2011 Mar 4;144(5):646-74
PMID: 21376230
-
From cradle to grave: the multiple roles of fibroblast growth factors in neural development.
Neuron. 2011 Aug 25;71(4):574-88
PMID: 21867876
-
Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer.
Cancer Biol Ther. 2011 Sep 1;12(5):388-98
PMID: 21709440
-
CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
Pathology. 2003 Apr;35(2):125-9
PMID: 12745459
-
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.
J Clin Invest. 2008 Jan;118(1):89-99
PMID: 18064304
-
Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin.
Exp Cell Res. 1999 May 25;249(1):54-64
PMID: 10328953
-
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.
J Clin Invest. 2013 Sep;123(9):3925-40
PMID: 23925295
-
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma.
Clin Cancer Res. 2013 Feb 15;19(4):920-8
PMID: 23362325
-
Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis.
Neoplasia. 2007 Jun;9(6):504-10
PMID: 17603633
-
CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
Exp Biol Med (Maywood). 2013 Mar;238(3):324-38
PMID: 23598979
-
Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
J Mol Diagn. 2013 Jul;15(4):498-507
PMID: 23747112
-
Role of heparan sulfate 2-o-sulfotransferase in prostate cancer cell proliferation, invasion, and growth factor signaling.
Prostate Cancer. 2011;2011:893208
PMID: 22135748
-
Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency.
Cytokine Growth Factor Rev. 2011 Aug;22(4):221-9
PMID: 21924665
-
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
Cancer Cell. 2007 Jan;11(1):53-67
PMID: 17222790
-
Glypican-3 expression is silenced in human breast cancer.
Oncogene. 2001 Nov 1;20(50):7408-12
PMID: 11704870
-
Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
Neoplasia. 2011 Aug;13(8):758-70
PMID: 21847367
-
The emerging role of TGF-beta superfamily coreceptors in cancer.
Biochim Biophys Acta. 2009 Oct;1792(10):954-73
PMID: 19607914
-
Heparan sulfate proteoglycans containing a glypican 5 core and 2-O-sulfo-iduronic acid function as Sonic Hedgehog co-receptors to promote proliferation.
J Biol Chem. 2013 Sep 6;288(36):26275-26288
PMID: 23867465
-
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.
World J Surg Oncol. 2012 Aug 24;10:170
PMID: 22917490
-
Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo.
J Biol Chem. 2009 Sep 18;284(38):26085-95
PMID: 19596856
-
Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor.
Chest. 2002 Mar;121(3 Suppl):6S-7S
PMID: 11893651
-
The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton.
Prostate Cancer. 2013;2013:418340
PMID: 24396604
-
Molecular modeling of protein-glycosaminoglycan interactions.
Arteriosclerosis. 1989 Jan-Feb;9(1):21-32
PMID: 2463827
-
Targeting MET in cancer: rationale and progress.
Nat Rev Cancer. 2012 Jan 24;12(2):89-103
PMID: 22270953
-
PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model.
PLoS One. 2012;7(12):e52175
PMID: 23300607
-
Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
BMC Cancer. 2013 Jan 17;13:24
PMID: 23327652
-
Amino acid determinants that drive heparan sulfate assembly in a proteoglycan.
J Biol Chem. 1994 Jul 29;269(30):19295-9
PMID: 8034692
-
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.
J Biol Chem. 2013 Mar 22;288(12):8176-8186
PMID: 23404505
-
The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.
Mol Biol Cell. 2011 May;22(9):1463-72
PMID: 21411633
-
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.
Nat Cell Biol. 2013 Jul;15(7):818-28
PMID: 23792691
-
Multi-faceted substrate specificity of heparanase.
Matrix Biol. 2013 Jun 24;32(5):223-7
PMID: 23499529
-
The role of syndecan-1 in malignancies.
Ann Med. 1996 Feb;28(1):63-7
PMID: 8932508
-
Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
Cancer Res. 2005 Nov 1;65(21):9899-905
PMID: 16267014
-
Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.
Cell Signal. 2009 Nov;21(11):1548-58
PMID: 19427900
-
Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.
Future Oncol. 2008 Dec;4(6):803-14
PMID: 19086847
-
Heparitin sulfate.
Biochim Biophys Acta. 1958 Aug;29(2):443-4
PMID: 13572372
-
The type III TGF-beta receptor suppresses breast cancer progression.
J Clin Invest. 2007 Jan;117(1):206-17
PMID: 17160136
-
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.
J Clin Invest. 2014 Jul;124(7):3016-31
PMID: 24937430
-
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
Clin Cancer Res. 2011 Mar 15;17(6):1382-93
PMID: 21257720
-
Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancement.
J Biol Chem. 1981 Nov 10;256(21):11065-72
PMID: 7287751
-
Heparan sulfate proteoglycans: intricate molecules with intriguing functions.
J Clin Invest. 2001 Jul;108(2):165-7
PMID: 11457866
-
Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma.
Lab Invest. 2006 Nov;86(11):1149-60
PMID: 16983329
-
The complex effects of heparins on cancer progression and metastasis in experimental studies.
Pharmacol Rev. 2001 Mar;53(1):93-105
PMID: 11171940
-
Microvascular heparin-like species with anticoagulant activity.
Am J Physiol. 1983 Nov;245(5 Pt 1):H725-33
PMID: 6356938
-
Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Invasion Metastasis. 1994-1995;14(1-6):290-302
PMID: 7657522
-
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.
Mol Cancer Res. 2008 Jan;6(1):1-9
PMID: 18234958
-
The multiple functions of collagen XVIII in development and disease.
Matrix Biol. 2011 Mar;30(2):83-92
PMID: 21163348
-
Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
Int J Cancer. 2009 Nov 1;125(9):2058-65
PMID: 19598263
-
Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells.
J Biol Chem. 2002 Aug 16;277(33):29730-6
PMID: 12055189
-
Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity.
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):7003-11
PMID: 16203794
-
Heparan sulfate proteoglycan expression in human lung-cancer cells.
Int J Cancer. 1997 Jun 20;74(3):335-45
PMID: 9221815
-
The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis.
J Gastrointest Cancer. 2008;39(1-4):149-58
PMID: 19373441
-
Role for amplification and expression of glypican-5 in rhabdomyosarcoma.
Cancer Res. 2007 Jan 1;67(1):57-65
PMID: 17210683
-
Roles for the type III TGF-beta receptor in human cancer.
Cell Signal. 2010 Aug;22(8):1163-74
PMID: 20153821
-
Heparin and heparan sulfate: structure and function.
Nat Prod Rep. 2002 Jun;19(3):312-31
PMID: 12137280
-
CD44 is required for two consecutive steps in HGF/c-Met signaling.
Genes Dev. 2002 Dec 1;16(23):3074-86
PMID: 12464636
-
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.
J Clin Invest. 2001 Aug;108(3):349-55
PMID: 11489925
-
Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
Neoplasia. 2013 Feb;15(2):112-24
PMID: 23441126
-
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
J Cell Mol Med. 2011 May;15(5):1013-31
PMID: 21155971
-
Order out of chaos: assembly of ligand binding sites in heparan sulfate.
Annu Rev Biochem. 2002;71:435-71
PMID: 12045103
-
Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins.
Int J Cell Biol. 2012;2012:676731
PMID: 22505933
-
Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
J Cell Biol. 2005 Nov 21;171(4):729-38
PMID: 16286510
-
Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition.
Cancer Res. 2013 Dec 1;73(23):7111-21
PMID: 24121493
-
Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients.
J Biol Chem. 2002 Jan 18;277(3):2089-96
PMID: 11706034
-
Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism.
J Biol Chem. 2011 Jul 22;286(29):25947-62
PMID: 21596751
-
In vivo footprinting analysis of the Glypican 3 (GPC3) promoter region in neuroblastoma cells.
Biochim Biophys Acta. 2007 Mar;1769(3):182-93
PMID: 17350117
-
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Carcinogenesis. 2009 Mar;30(3):397-407
PMID: 19126645
-
Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Clin Cancer Res. 2004 Aug 1;10(15):5178-86
PMID: 15297422
-
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Cancer Res. 2001 Jul 15;61(14):5562-9
PMID: 11454708
-
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.
J Clin Invest. 2001 Aug;108(3):341-7
PMID: 11489924
-
Stromal endothelial cells directly influence cancer progression.
Sci Transl Med. 2011 Jan 19;3(66):66ra5
PMID: 21248315
-
Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix.
J Pathol. 1994 Apr;172(4):349-55
PMID: 8207616
-
Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
Oncogene. 2006 Mar 2;25(9):1408-12
PMID: 16247452
-
Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.
PLoS One. 2013 Nov 12;8(11):e79634
PMID: 24265783
-
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
Hepatology. 2008 Apr;47(4):1211-22
PMID: 18318435
-
PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer.
Mol Cancer Ther. 2013 Jul;12(7):1190-201
PMID: 23696215
-
Heparin-protein interactions.
Angew Chem Int Ed Engl. 2002 Feb 1;41(3):391-412
PMID: 12491369
-
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer.
Ann Oncol. 2010 Jun;21(6):1302-1307
PMID: 19917571
-
miR-331-3p regulates expression of neuropilin-2 in glioblastoma.
J Neurooncol. 2014 Jan;116(1):67-75
PMID: 24142150
-
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage.
J Hepatol. 2009 May;50(5):958-68
PMID: 19303160
-
Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
J Biol Chem. 2007 May 4;282(18):13326-33
PMID: 17347152
-
Heparan sulfate is required for bone morphogenetic protein-7 signaling.
Biochem Biophys Res Commun. 2003 Sep 5;308(4):858-65
PMID: 12927798
-
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.
Lancet Oncol. 2010 Apr;11(4):321-30
PMID: 20304703
-
Fibroblast growth factor signalling: from development to cancer.
Nat Rev Cancer. 2010 Feb;10(2):116-29
PMID: 20094046
-
Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis.
Mol Cancer Res. 2012 May;10(5):597-604
PMID: 22522458
-
Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Hum Pathol. 2007 Oct;38(10):1508-15
PMID: 17640714
-
Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions.
J Biol Chem. 1998 Aug 28;273(35):22825-32
PMID: 9712917
-
Efficacy and safety of adjunctive anticoagulation in patients with lung cancer without indication for anticoagulants: a systematic review and meta-analysis.
Thorax. 2013 May;68(5):442-50
PMID: 23321607
-
Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.
Mol Cell Proteomics. 2006 Jan;5(1):157-71
PMID: 16215274
-
Expression and prognostic role of syndecan-2 in prostate cancer.
Prostate Cancer Prostatic Dis. 2010 Mar;13(1):78-82
PMID: 19786981
-
The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.
Urol Oncol. 2010 Sep-Oct;28(5):534-40
PMID: 19450993
-
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
J Biol Chem. 2000 Aug 11;275(32):24653-60
PMID: 10816596
-
Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88.
Glycobiology. 2010 Feb;20(2):175-86
PMID: 19822709
-
P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
FASEB J. 2007 Nov;21(13):3562-72
PMID: 17557930
-
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.
Cell. 1994 Dec 16;79(6):1005-13
PMID: 7528102
-
Immunohistochemical study of glypican 3 in thyroid cancer.
Oncology. 2007;73(5-6):389-94
PMID: 18511877
-
Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.
Eur J Cancer. 2004 Jun;40(9):1373-82
PMID: 15177497
-
Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo.
Int J Cancer. 2010 Mar 15;126(6):1291-301
PMID: 19816934
-
Targeting the PDGF signaling pathway in tumor treatment.
Cell Commun Signal. 2013 Dec 20;11:97
PMID: 24359404
-
The effect of anticoagulants on cancer risk and survival: systematic review.
Cancer Treat Rev. 2007 Jun;33(4):358-68
PMID: 17408861
-
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Am J Surg Pathol. 2008 Apr;32(4):600-7
PMID: 18277882
-
Nonheparin anticoagulants for heparin-induced thrombocytopenia.
N Engl J Med. 2013 Feb 21;368(8):737-44
PMID: 23425166
-
Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae.
Acta Neuropathol. 2004 Apr;107(4):311-8
PMID: 14735305
-
Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1.
J Biol Chem. 2003 Apr 11;278(15):13069-76
PMID: 12556525
-
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
Carcinogenesis. 2008 Jul;29(7):1319-26
PMID: 18413366
-
Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma.
Cancer. 2002 Jan 1;94(1):258-63
PMID: 11815985
-
The utility of hedgehog signaling pathway inhibition for cancer.
Oncologist. 2012;17(8):1090-9
PMID: 22851551
-
Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
J Clin Invest. 1998 Oct 15;102(8):1599-608
PMID: 9788974
-
Neuropilins in tumor biology.
Clin Cancer Res. 2009 Mar 15;15(6):1860-4
PMID: 19240167
-
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):627-38
PMID: 19822079
-
Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.
Mol Cells. 2009 May 31;27(5):503-13
PMID: 19466598